Trileptal 300 MG Oral Tablet
- RxCUI
- 261360
- RxNorm name
- Trileptal 300 MG Oral Tablet
- Display name
- Trileptal 300 MG Oral Tablet
- Full name
- Trileptal 300 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trileptal | OXCARBAZEPINE | Novartis Pharmaceuticals Corporation | 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | 2025-12-16 | Warnings, Adverse reactions | 261360 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | Trileptal 300 MG Oral Tablet [PSN] · oxcarbazepine 300 MG Oral Tablet [Trileptal] [SBD] · Trileptal 300 MG Oral Tablet [SY] | 3 | 39 | These highlights do not include all the information needed to use TRILEPTAL safely and effectively. See full prescribing information for TRILEPTAL. TRILEPTAL ® (oxcarbazepine) film-coated tablets, for oral use TRILEPTAL ® (oxcarbazepine) oral suspension Initial U.S. Approval: 2000 | 20251216 |
| 33af9350-95f3-384e-e054-00144ff88e88 | Trileptal 300 MG Oral Tablet [PSN] · oxcarbazepine 300 MG Oral Tablet [Trileptal] [SBD] · Trileptal 300 MG Oral Tablet [SY] | 3 | 1 | OXCARBAZEPINE | 20160525 |
| d9741f36-0abd-49b7-9f43-e9700663122b | Trileptal 300 MG Oral Tablet [PSN] · oxcarbazepine 300 MG Oral Tablet [Trileptal] [SBD] · Trileptal 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use Trileptal safely and effectively. See full prescribing information for Trileptal . Trileptal ® ( oxcarbazepine ) film-coated tablets Trileptal ® ( oxcarbazepine ) oral suspension for oral administration Initial U.S. Approval: 2000 | 20120217 |